| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |